(1 - 8 from 10
)
Novel Approach to Adoptive Immunotherapy Developed by NexImmune's...
www.finanznachrichten.de
Dr. Mathias Oelke, Scientific Co-founder and Senior Director of Discovery at NexImmune and co-author on the publication, noted the broad ...
NexImmune Announces $3 Million Financing | NEA | New Enterprise...
www.nea.com
... (AIM™) nanotechnology. The AIM technology, which was first developed by Drs. Mathias Oelke and Jonathan Schneck at The Johns Hopkins University, ...
NexImmune Makes Appointments to its Board | Technology Networks
www.technologynetworks.com
Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters.
sorted by relevance / date